Search General Info
Search Education
Search Partnering Companies
photo
Speaker

Wankyu Kim

CEO, KAIPHARM CO., LTD.
Seoul, Korea, Republic of
Wankyu Kim, PhD is an expert in bioinformatics and in silico systems biology. He is a professor in Life Science, Ewha Womans Univ. since 2009 and a CEO of KaiPharm, a venture company for AI-driven drug discovery founded in Nov. 2018 together with his colleagues. Prior to current position, he received B.S./M.S. at the Department of Microbiology in Seoul National University in Korea, and PhD in Bioinformatics at the University of Cambridge, UK. Then, he was trained as post-doc at Edward Marcotte’s lab of Univ. of Texas, Austin.
His recent work is focused on the subject of ‘in silico systems pharmacology’ or ‘Data-Driven Drug Discovery’ for developing analytic tools and algorithms for early-stage drug discovery. In particular, he first proposed a novel idea of ‘Assay Repositioning’ i.e. reuse of compound screening dataset in virtual screening for the targets different from their original purposes, and has a broad experience in large-scale mining of drug-induced transcriptome data (CMAP).
Speaking In
[Available On-Demand]
KaiPharm is an AI-Data-driven drug discovery company located in Seoul, Korea. Our technology…